Local reactions to treatments with viscum album L. extracts and their association with T-lymphocyte subsets and quality of life

Anticancer Research

Volumn 28, Issue 3 B, 2008, Pages 1893-1897

  Büssing, Arndt ^a,b   Tröger, Wilfried ^c   Stumpf, Cristina ^d   Schietzel, Michael ^b,d  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Krebsforschung Herdecke eV   (Germany)

^c Krebsforschung Herdecke   (Germany)

^d Gemeinschaftskrankenhaus Herdecke   (Germany)

Author keywords

Cancer patients; Local reactions; Mistletoe; Peripheral lymphocytes; Quality of life; Viscum album

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; VISCUM ALBUM EXTRACT;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER PATIENT; CD4+ T LYMPHOCYTE; COLORECTAL CANCER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VISCUM ALBUM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PROTEINS; QUALITY OF LIFE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VISCUM ALBUM;

EID: 45949086376     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Büssing A: Mistletoe - The Genus Viscum. Amsterdam, Harwood Academic Publishers, 2000.
2. Kienle GS and Kiene H (eds.): Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen. Stuttgart, Schattauer, 2003.
3. Kienle GS, Berrino F, Büssing A, Portalupi E, Rosenzweig S and Kiene H: Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res 8: 109-119, 2003.
4. Janssen O, Scheffler A and Kabelitz D: In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Arzneimittelforschung 43: 1221-1227, 1993.
5. Büssing A, Suzart K, Bergmann J, Pfuller U, Schietzel M and Schweizer K: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 99: 59-72, 1996.
6. + cells with a 'memory' phenotype (CD62Llo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L. Cell Death Differ 5: 231-240, 1998.
7. Büssing A, SchallerG and Pfüller U: Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L. Anticancer Res 18: 4291-4296, 1998.
8. Büssing A, Vervecken W, Wagner M, Wagner B, Pfuller U and Schietzel M: Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry 37: 133-139, 1999.
9. Berg PA and Stein GM: Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische Analyse. Dtsch Med Wochenschr 126: 339-345, 2001.
10. Büssing A, Stumpf C, Tröger W and Schietzel M: Course of mitogen stimulated T lymphocytes in cancer patients treated with Viscum album extracts. Anticancer Res 27: 2903-2910, 2007.
11. Ostermann T, Büssing A, Beer AM and Matthiessen PF: The Herdecke questionnaire on quality of life (HLQ): Validation of factorial structure and development of a short form within a naturopathy treated in-patient collective. Quality of Life Outcomes 3: 40, 2005 (http://www.hqlo.com/content/3/l/40) .
12. Schulte M, Heckmann C and Kümmell HC: Der Herdecker Fragebogen zur Lebensqualität (HLQ): Entwicklung, Ergebnisse, Verwendungsmö glichkeiten. In: Akademische Forschung in der Anthroposophischen Medizin. Heusser P (eds.). Bern, Peter Lang Verlag, pp. 249-253, 2000.